BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2022 12:39:21 AM | Browse: 230 | Download: 455
Publication Name World Journal of Clinical Cases
Manuscript ID 70792
Country China
Received
2021-08-15 02:16
Peer-Review Started
2021-08-15 02:21
To Make the First Decision
Return for Revision
2021-10-20 20:50
Revised
2021-10-30 13:49
Second Decision
2022-01-25 03:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-01-26 22:15
Articles in Press
2022-01-26 22:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-02-19 14:56
Publish the Manuscript Online
2022-03-11 00:39
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Geriatrics & Gerontology
Manuscript Type Case Report
Article Title Idarucizumab reverses dabigatran-induced anticoagulation in treatment of gastric bleeding: A case report
Manuscript Source Unsolicited Manuscript
All Author List Yu Jia, Shao-Hua Wang, Na-Juan Cui, Quan-Xi Liu, Wei Wang, Xue Li, Ya-Mei Gu and Yan Zhu
ORCID
Author(s) ORCID Number
Yu Jia http://orcid.org/0000-0002-1743-4943
Shao-Hua Wang http://orcid.org/0000-0002-9085-5218
Na-Juan Cui http://orcid.org/0000-0002-7867-6153
Quan-Xi Liu http://orcid.org/0000-0002-6526-2840
Wei Wang http://orcid.org/0000-0001-5057-5433
Xue Li http://orcid.org/0000-0001-8880-1133
Ya-Mei Gu http://orcid.org/0000-0001-7173-1183
Yan Zhu http://orcid.org/0000-0001-5906-1412
Funding Agency and Grant Number
Corresponding Author Yan Zhu, MS, Attending Doctor, gastroenterology, Hospital of Integrated Traditional Chinese and Western Medicine, No.3 East Yongding Road, Haidian District, Beijing 100039, China. zy815925@163.com
Key Words Idarucizumab; Dabigatran; Gastric bleeding; Atrial fibrillation; Case report
Core Tip The anticoagulatory effect of dabigatran resolves completely after five half-lives, which is approximately 2.5-3.5 d after the last dose for patients with normal renal function. Thrombin time (TT) is sensitive to the effects of dabigatran and can be prolonged even with trivial amounts of the drug. This patient exhibited persistent bleeding in the normal coagulation test (except for TT), possibly due to the anticoagulatory effects of the drug administered 4 days after the last dose for her renal insufficiency. Therefore, idarucizumab was administered for hemostasis, thus stopping the bleeding. This case highlights the importance of regular monitoring of renal function in older patients.
Publish Date 2022-03-11 00:39
Citation Jia Y, Wang SH, Cui NJ, Liu QX, Wang W, Li X, Gu YM, Zhu Y. Idarucizumab reverses dabigatran-induced anticoagulation in treatment of gastric bleeding: A case report. World J Clin Cases 2021; 10(8): 2537-2542
URL https://www.wjgnet.com/2307-8960/full/v10/i8/2537.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i8.2537
Full Article (PDF) WJCC-10-2537.pdf
Full Article (Word) WJCC-10-2537.docx
CARE Checklist–2016 70792-CARE-Checklist–2016-revision.pdf
Manuscript File 70792_Auto_Edited.docx
Answering Reviewers 70792-Answering reviewers.pdf
Audio Core Tip 70792-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 70792-Conflict-of-interest statement.pdf
Copyright License Agreement 70792-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s) 70792-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 70792-Language certificate.pdf
Peer-review Report 70792-Peer-review(s).pdf
Scientific Misconduct Check 70792-Bing Wu YXJ-2.png
Scientific Editor Work List 70792-Scientific editor work list.pdf